MARKET

NSPR

NSPR

INSPIREMD
AMEX

Real-time Quotes | Nasdaq Last Sale

1.170
+0.010
+0.86%
After Hours: 1.220 +0.05 +4.27% 16:53 02/20 EST
OPEN
1.190
PREV CLOSE
1.160
HIGH
1.210
LOW
1.150
VOLUME
83.19K
TURNOVER
--
52 WEEK HIGH
9.19
52 WEEK LOW
0.7401
MARKET CAP
4.04M
P/E (TTM)
-0.1251
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NSPR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NSPR News

  • InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2020
  • GlobeNewswire.01/29 13:00
  • InspireMDs CGuard Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany
  • GlobeNewswire.01/27 13:00
  • DexCom (DXCM) Hits Fresh High: Is There Still Room to Run?
  • Zacks.01/08 14:15
  • PLUG, NIO among premarket gainers
  • Seeking Alpha - Article.01/06 14:17

More

Industry

Medical Equipment, Supplies & Distribution
-0.50%
Healthcare Equipment & Supplies
-0.62%

Hot Stocks

Name
Price
%Change

About NSPR

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
More

Webull offers InspireMD Inc (NSPR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.